Tenovid Dosage/Direction for Use

Always take this medicine exactly as prescribed. Patients must be advised.
The recommended dose is: Adults: 1 tablet each day with food (for example, a meal or a snack).
Adolescents aged 12 to less than 18 years who weigh at least 35 kg: 1 tablet each day with food (for example, a meal or a snack).
Always take the dose as recommended. This is to make sure that the medicine is fully effective, and to reduce the risk of developing resistance to the treatment. The dose should not be changed unless prescribed.
If the patient is an adult and has problems with the kidneys, Tenovid may be taken less frequently.
Refer to the patient information leaflets of the other antiretrovirals for guidance on how to take those medicines.
Forgotten intake of Tenovid: It is important not to miss a dose of Tenovid. For missed doses, the patient should work out how long since they should have taken it.
If it is less than 12 hours after it is usually taken, it should be taken as soon as the patient can, and the next dose should be taken at its regular time.
If it is more than 12 hours since the patient should have taken it, the missed dose should be forgotten. The patient should wait and the next dose should be taken at the regular time. A double dose should not be taken to make up for a forgotten tablet.
If the patient throws up less than 1 hour after taking Tenovid, another tablet should be taken. There's no need to take another tablet if the patient is sick more than 1 hour after taking Tenovid.
Stopping intake of Tenovid: Advise the patient not to stop taking Tenovid without the doctor's advice. Stopping treatment with Tenovid may reduce the effectiveness of the treatment as recommended.
If the patient has hepatitis B or HIV and hepatitis B together (co-infection), it is very important to advise the patient not to stop the Tenovid treatment without talking to the doctor first. Some patients have had blood tests or symptoms indicating that their hepatitis has gotten worse after stopping Tenovid. The patient may require blood tests for several months after stopping treatment. In some patients with advanced liver disease or cirrhosis, stopping treatment is not recommended as this may lead to worsening of hepatitis.
Advise the patient to talk to the doctor before stopping Tenovid for any reason, particularly if the patient is experiencing any side effects or has another illness.
Advise the patient to inform the doctor immediately about new or unusual symptoms after stopping treatment, particularly symptoms the patient associates with hepatitis B infection.
Advise the patient to contact the doctor before restarting Tenovid tablets.
Patients must be advised regarding further questions on the use of this medicine.